Sudden Cardiac Arrest in an Asymptomatic Zinc Phosphide-Poisoned Patient: A Case Report.
Parinaz ParhizgarReza ForouzanfarSeyed Kaveh HadeiyNasim ZamaniHossein Hassanian-MoghaddamPublished in: Cardiovascular toxicology (2021)
Zinc phosphide is a gray to black powder mainly used as a rodenticide. In contact with gastric fluid, it releases phosphine which is the main toxic material of this compound. Phosphine interferes with oxidative respiratory cycle of the cells, but is generally expected to manifest its toxicity with prodromal signs and symptoms including abdominal pain, nausea and vomiting, metabolic acidosis, and increased liver function tests. A 64-year-old man was referred to our center with the history of ingestion of three full table spoons of zinc phosphide powder with only a mild GI discomfort. Abdominal X-ray revealed radiopaque material in epigastric and abdominal right upper quadrant. Despite treatment with polyethylene glycol and completely normal vital signs and lab tests, he experienced sudden cardiac arrest 19 h after admission. Autopsy showed clues of focal myopathy and fibrosis with evidences of ischemia and congestion in cardiac tissue, pulmonary edema, shrunken bilateral kidneys, and nutmeg yellow liver. Toxicology panel confirmed the presence of phosphine and zinc phosphide in the gastric fluid. The patient deteriorated suddenly despite being completely symptom-free during the hours preceding cardiovascular arrest. Since the cardiopulmonary injury is the most rampant cause of early death, checking of the cardiac enzymes and cardiac monitoring could be beneficial for early detection and efficient management of these patients.
Keyphrases
- cardiac arrest
- oxide nanoparticles
- abdominal pain
- cardiopulmonary resuscitation
- left ventricular
- case report
- end stage renal disease
- newly diagnosed
- chronic kidney disease
- ejection fraction
- induced apoptosis
- emergency department
- oxidative stress
- peritoneal dialysis
- heart failure
- late onset
- patient reported
- prognostic factors
- high resolution
- computed tomography
- patient reported outcomes
- magnetic resonance imaging
- parkinson disease
- cell cycle arrest
- physical activity
- early onset
- depressive symptoms
- duchenne muscular dystrophy
- sleep quality
- replacement therapy
- dual energy
- deep brain stimulation